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Abstract
Phosphorylation of actin-binding proteins plays a pivotal role in the remodeling of the actin cytoskeleton to regulate cell
migration. Palladin is an actin-binding protein that is phosphorylated by growth factor stimulation; however, the identity of
the involved protein kinases remains elusive. In this study, we report that palladin is a novel substrate of extracellular signal-
regulated kinase (ERK). Suppression of ERK activation by a chemical inhibitor reduced palladin phosphorylation, and
expression of active MEK alone was sufficient for phosphorylation. In addition, an in vitro kinase assay demonstrated direct
palladin phosphorylation by ERK. We found that Ser77 and Ser197 are essential residues for phosphorylation. Although the
phosphorylation of these residues was not required for actin cytoskeletal organization, we found that expression of non-
phosphorylated palladin enhanced cell migration. Finally, we show that phosphorylation inhibits the palladin association
with Abl tyrosine kinase. Taken together, our results indicate that palladin phosphorylation by ERK has an anti-migratory
function, possibly by modulating interactions with molecules that regulate cell migration.
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Introduction
The actin cytoskeleton plays pivotal roles for many fundamental
processes, such as cell migration and cell division. These processes
are accompanied with dynamic remodeling of the actin cytoskel-
eton, which is regulated by various actin-binding proteins.
Extracellular stimuli such as growth factors and integrin
engagement activate protein kinases, including MAPK, Src and
AKT [1]. These kinases phosphorylate actin-binding proteins to
control rearrangement of the actin cytoskeleton [2]. Identification
of the actin-binding proteins that are phosphorylated by these
kinases is essential to elucidate the molecular mechanisms by
which extracellular stimuli regulate cell migration and shape
changes.
Palladin, myotilin and myopalladin are a family of closely
related actin-binding proteins that are expressed in a variety of
muscle and non-muscle cells [2]. Among these proteins, palladin is
the most abundantly expressed molecule in diverse tissues and cell
lines. There are three major isoforms of palladin with apparent
molecular masses of 90, 140 and 200 kDa that have proline-rich
sequences and multiple IgC2 (immunoglobulin C2- type) domains
[3]. Palladin is localized on actin-based subcellular structures, e.g.,
stress fibers, focal adhesions and podosomes [4–7]. Palladin has a
number of associating proteins, including alpha-actinin [8],
CLP36 [9] and other molecules that might affect actin
organization. This implies palladin may function as a scaffolding
molecule to recruit proteins to the actin cytoskeleton [6,10–14]. In
addition, palladin directly associates with F-actin to induce the
bundling of actin filaments [15].
Accumulating evidence has shown that palladin is essential for
remodeling of the actin cytoskeleton to control cell migration and
invasion. Suppression of palladin expression in fibroblasts by
antisense transfections results in a disruption of actin cytoskeletal
organization [5]. In addition, fibroblasts derived from palladin-
deficient mice show disruptions in cell motility, adhesion, and actin
organization [16,17]. Conversely, palladin overexpression in Cos7
cells and astrocytes increases the number and size of actin bundles
[11,18]. Palladin is also required for the invasion of breast cancer
cells. Palladin is highly expressed in invasive breast cancer cells,
and suppression of palladin expression reduces cell invasion [7].
Recent studies have shown that AKT1, which is a protein kinase
essential for cell survival and cancer progression, phosphorylates
palladin to regulate actin bundling and cell migration [19].
Although these studies indicate an essential role for palladin in cell
migration and invasion, the precise mechanisms still remain
unclear.
Extracellular signal-regulated kinase (ERK) is one of the
essential molecules for the regulation of diverse cellular events
including proliferation, migration, differentiation and survival
[20,21]. ERK is activated in response to various extracellular
stimuli through the Ras-Raf-MEK pathway and then translocates
into the nucleus to phosphorylate transcription factors [22].
Activated ERK also translocates to focal adhesions to regulate the
formation of actin filaments and focal adhesions required for cell
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demonstrated that ERK phosphorylates proteins, e.g., myosin
light chain kinase [24], vinexin [25], paxillin [26], focal adhesion
kinase [27], Eplin [28] and actopaxin [29], to regulate cell
migration.
Palladin is a known phosphoprotein, but the identities of the
protein kinases that are responsible for its phosphorylation remain
uncertain. In this study, we show evidence that palladin is a novel
ERK substrate. In addition, we show that palladin phosphoryla-
tion by ERK is involved in cell migration and an association with
Abl tyrosine kinase.
Materials and Methods
Ethics statement
Use of a rabbit to produce anti-palladin antibody was approved
by Committee of Animal Experiment in Nagoya University
Graduate School of Medicine (Approved ID: 23130).
Cell culture, antibodies and chemicals
Cells except MCF10A cells [30] were cultured in DMEM
(Sigma, St. Louis, MO) supplemented with 10% FBS and
antibiotics. MCF10A cells were maintained in DMEM-F12
(Invitrogen, Carlsbad, CA) supplemented with 0.1 mg/ml cholera
toxin (Sigma), 0.02 mg/ml epidermal growth factor (PeproTech,
Rocky Hill, NJ), 10 mg/ml insulin (Sigma), 0.5 mg/ml hydrocor-
tisone (Sigma), and antibiotics. To produce an anti-palladin
antibody, amino acids 705–772 of palladin were fused with GST
for bacterial production, and recombinant protein was purified
using glutathione agarose (Sigma). The protein was mixed with
Freund’s adjuvant (Sigma) and injected into a rabbit four times.
The serum was then obtained. To purify the anti-palladin
antibody, we used a HiTrap NHS-activated HP column (GE
Healthcare BioSciences, Uppsala, Sweden) coupled with recom-
binant GST-palladin (705–772). Anti-HA antibody was obtained
from Roche (Basel, Switzerland), anti-ERK, anti-phospho-tyrosine
(PY20) and anti-Myc (9E10) antibodies were from Santa Cruz
Biotechnology (Santa Cruz, CA), anti-GFP antibody was from
Nacalai Tesque (Tokyo, Japan), anti-MPM2 antibody was from
Millipore (Billerica, MA), anti-Rac, anti-Cdc42 and anti-Abl
antibodies were from BD Biosciences (San Jose, CA), and anti-
phospho-ERK antibody was from Cell Signaling (Tokyo, Japan).
Epidermal Growth Factor (EGF) and Platelet Derived Growth
Factor (PDGF) were purchased from PeproTech (Rocky Hill, NJ).
U0126 and LY294002 were obtained from Wako (Osaka, Japan),
and STI571 was from Cayman chemical (Ann Arbor, MI).
Generation of palladin and mutant constructs
Palladin was amplified by PCR using the cDNA clone
KIAA0992, which was kindly provided by Kazusa DNA Research
Institute. The palladin constructs were numbered by amino acids
based on the previously published sequence [4]. To produce
palladin deletion constructs, DNA fragments were amplified by
PCR and cloned into the pcDNA3.1 vector (Invitrogen). Amino
acid substitutions were performed by PCR as previously described
[31] and each mutation was confirmed by sequencing.
Alkaline phosphatase treatment
Cells were lysed in TNE buffer (Tris-HCl 25 mM (pH7.4),
NaCl 150 mM, 1% NP40) containing a cocktail of phosphatase
inhibitors (Nacalai Tesque, Tokyo, Japan). Endogenous and HA-
tagged palladin were immunoprecipitated with anti-palladin and
anti-HA antibody, respectively. Immunoprecipitates were either
not treated or treated with 10 units of alkaline phosphatase (New
England Biolabs, Ispwich, MA) at room temperature for 30 min
and subjected to western blot analysis.
Generation of cell lines
To establish MDA-MB-231 [32] and MCF10A cell lines that
constitutively expressed GFP, GFP-wt (GFP-tagged wild-type
palladin) and GFP-S77.197G (GFP-tagged mutant palladin), each
cDNA was cloned into a pQCXIN retrovirus vector (Clontech,
Mountain View, CA). Silent mutations were introduced in GFP-wt
and GFP-S77.197G palladin to be resistant to shRNA targeting
endogenous palladin. Each plasmid was transfected into HEK
293T cells [30] together with pVPack-GP and pVPack-Ampho
vectors (Stratagene, Tokyo, Japan) using Lipofectamine 2000
(Invitrogen) according to the manufacturer’s protocol. Culture
supernatants were collected 48 h after transfection and applied to
MDA-MB-231 and MCF10A cells in combination with 2 mg/ml
polybrene (Sigma). Cells were cultured for 24 h, and infected cells
were selected with 400 mg/ml of G418 (Nacalai Tesque, Tokyo,
Japan). To establish shLuc/GFP, shPal/GFP, shPal/GFP-wt and
shPal/GFP-S77.197G cells, oligonucleotides encoding shRNAs
specific for human palladin (59-GCACAAAGGATGCTGTTAT-
39) and luciferase (59-CTTACGCTGAGTACTTCGA-39) were
cloned into the pSIREN-RetroQ retroviral vector (Clontech).
Cells were infected with recombinant retroviruses that encoded
each shRNA and were selected with 1 mg/ml puromycin. To
produce 293T/HA-wt cells, we cloned full-length palladin (amino
acids 1–772) cDNA into a pQCXIP retrovirus vector with an N-
terminal 46 HA-tag (Clontech). HEK 293T cells were infected
with the recombinant virus and selected with 1 mg/ml puromycin.
Western blot
Cell lysates were loaded on SDS-polyacrylamide gels for
electrophoresis and transferred to polyvinylidene difluoride
membranes (Millipore). Membranes were blocked with 1% skim
milk for 1 h, incubated with primary antibodies for 1 h, washed
with TBS-T for 15 min and incubated with HRP-labeled
secondary antibodies. Signals were detected with ECL system
(GE Healthcare BioSciences). Signal intensities were measured
using Light Capture II equipped with CS analyzer (ATTO Corp.,
Tokyo, Japan). To detect palladin mobility shifts, serum-starved
cells were stimulated with EGF (20 ng/ml) or PDGF (10 ng/ml)
for 5 min and lysed with SDS sample buffer. To detect mobility
shifts of exogenously expressed palladin, cells were transfected with
mutant palladin. Twenty-four hours later, cells were serum-starved
and stimulated with EGF (20 ng/ml) for 5 min.
In vitro kinase assay
A GST-fused palladin fragment (amino acids 45–249) was
purified from bacteria under native conditions. Purified active
ERK was purchased from Millipore (Billerica, MA). One
nanogram of active ERK was incubated with 1 mg of wild-type
or mutant GST-palladin (45–249) bound to glutathione beads in
the presence of [c
322P]-ATP for 10 min. The reaction mixture
was washed three times with PBS. Precipitates were separated by
SDS-PAGE and analyzed by autoradiography.
Pull-down assay
To produce GST-fused proteins, cDNAs encoding fragments of
each protein were cloned into a 5X-1 vector (GE Healthcare
BioSciences) at the EcoRI-NotI site. GST-fused proteins were
produced in bacteria and purified using glutathione agarose. To
examine the association of palladin with GST-fused proteins,
serum-starved 293T/HA-wt or 293T/HA-S77.197G cells were
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lysed with TNF buffer. After centrifugation at 15,000 rpm for
10 min, supernatants were mixed with GST-fused proteins bound
to glutathione agarose. Affinity precipitated proteins were
separated by SDS-PAGE, transferred to PVDF membrane and
probed with anti-Myc antibody.
Migration assay
Cells were serum-starved for 2 h and suspended in serum-free
media after trypsin inactivation. Cells (5610
4) in 200 ml were
loaded onto the upper surface of a Boyden chamber with EGF
(20 ng/ml) in the lower chamber. Cells were allowed to migrate
into the lower surface of the filter for 2 h (MDA-MB-231 cells) or
4 h (MCF10A cells) and fixed with 70% ethanol. Cells on the
upper surface of the filter were removed with a cotton swab and
stained with crystal violet. Cells that migrated to the lower surface
of the chamber were counted in five randomly selected fields and
average numbers of migrated cells were calculated for each cell
line. To determine the ratio of migrated cells relative to shLuc/
GFP cells, average numbers of migrated cells from five
independent fields were divided by the average number of
migrated shLuc/GFP cells. Three independent experiments were
performed. Results were compared using Student’s t test and
considered significant when p was ,0.05. To examine cell
migration in the presence of STI571, serum-starved cells were
treated with the different concentrations of STI571 for 2 h and
Figure 1. Palladin is phosphorylated upon growth factor stimulation. (A) Indicated cells were serum-starved and stimulated with EGF
(20 ng/ml) or PDGF (10 ng/ml). Five min after the stimulation, cells were lysed and probed with anti-palladin or anti-HA antibody. Arrows indicate
mobility shifted palladin. (B) Serum-starved MCF10A and 293T/HA-wt cells were treated with EGF and 5 min later cells were lysed with TNE buffer. The
lysates were immunoprecipitated with either anti-palladin or anti-HA antibody and incubated with or without alkaline phosphatase for 30 min.
Immunoprecipitates were subjected to immunoblotting with the indicated antibody. Arrows indicate mobility shifted palladin. (C) 293T/HA-wt cells
were serum-starved and treated or non-treated with EGF for 5 min and then immmunoprecipitated with anti-HA antibody. The immunoprecipitates
were probed with the indicated antibodies. Whole cell extract of v-Src transformed cells (SR3Y1) was used as a control for anti-phospho-tyrosine
antibody (PY20).
doi:10.1371/journal.pone.0029338.g001
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chamber. STI571 was added to the upper and lower chamber
during cell migration. To determine cell migration in the absence
of Abl expression, cells were transfected with either luciferase or
Abl siRNA and 48 h later, cells were serum-starved and migration
was assessed.
siRNA transfection
siRNA against Abl and luciferase was designed and synthesized
by Sigma. The sequence of the Abl siRNA is 59-GGGUGUAC-
CAUUACAGGAUTT-39 and the luciferase siRNA is 59-
CUUACGCUGAGUACUUCGATT-39. Cells were transfected
with 20 nM siRNA using Lipofectamine RNAiMAX (Invitrogen)
according to the manufacturer’s protocol.
Rac and Cdc42 activity assay
Cells were lysed with pull-down lysis buffer [50 mM Tris-
HCl(pH7.4), 200 mM NaCl, 1% Nonidet P-40, 10% Glycerol,
10 mM MgCl2, and 1 mM EDTA] and incubated with GST-PAK-
PBD (residues 67–150) fusion protein bound to glutathione agarose
beads for 1 h. Beads were washed with pull-down buffer for four
times and then subjected to western blot with anti-Rac and anti-
Cdc42antibodiestodetectactiveproteinsbound tothebeads.Total
proteins were detected by immunoblotting cell lysates.
Figure 2. Palladin phosphorylation is dependent on the MEK/ERK pathway. (A) Serum-starved Vero cells were treated with EGF in the
presence or absence of the indicated inhibitors. Five minutes after stimulation, cells were lysed and immunoblotted with anti-palladin antibody. (B)
HeLa cells were treated as in (A) and immunblotted with anti-palladin antibody. Arrows indicate 90 kDa and 140 kDa form of palladin. (C) Cos7 cells
were transfected with HA-palladin together with or without active MEK (MEK1/EEDN3). Twenty-four hours later, cells were lysed and immunoblotted
with the indicated antibodies. (D) MDA-MB-231 cells were cultured on glass coverslips and stimulated with EGF for 5 min and then fixed to
immunostain for palladin (green) and phospho-ERK (red). Pictures were taken using an A1Rsi confocal microscopy (Nikon). Images in the bottom
panel are partially enlarged images of the squared fields of the pictures. (Upper panels; scale bar=50 mm, Lower panels; scale bar=15 mm).
doi:10.1371/journal.pone.0029338.g002
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Palladin is phosphorylated by growth factor stimulation
Western blot analysis with a polyclonal palladin antibody
revealed a mobility shift of palladin in cells stimulated with EGF
and PDGF (Fig. 1A), which is consistent with a previous report by
Goicoechea et al. [6]. We also examined the mobility shift of
exogenously expressed palladin. Full-length palladin was amplified
by PCR using cDNA clone KIAA0992 and cloned into an N-
terminally 46 HA-tagged pQCXIP retrovirus vector. We
established 293T cells that constitutively expressed HA-tagged
palladin (293T/HA-wt) by retrovirus infection and observed the
clear appearance of a slower migrating form of HA-palladin by
EGF stimulation (Fig. 1A). To determine if the mobility shift was
due to phosphorylation, we used alkaline phosphatase. Palladin
was immunoprecipitated from the lysates of EGF-treated
MCF10A or 293T/HA-wt cells and then treated with alkaline
phosphatase. As shown in Figure 1B, alkaline phosphatase
treatment eliminated the mobility shift of both endogenous and
exogenous palladin. This mobility shift is often observed after the
phosphorylation of serine or threonine residues followed by
proline. To confirm the phosphorylation of serine or threonine
residues of palladin, we used an anti-MPM2 antibody that
recognizes a phosphorylated epitope (Ser/Thr)-Pro. As shown in
Figure 1C, only a mobility-shifted form of palladin was detected by
the anti-MPM2 antibody. Anti-phospho-tyrosine antibody did not
react with palladin in EGF-treated cells (Fig. 1C). These results
indicate that palladin is phosphorylated at serine or threonine in
response to growth factor stimulation.
MEK/ERK is responsible for palladin phosphorylation
To determine which protein kinases are essential for phosphor-
ylation, we used a MEK inhibitor (U0126) and a PI3K inhibitor
(LY294002). Serum-starved cells were incubated with U0126
(5 mM) or LY294002 (10 mM) for 1 h and stimulated with EGF
(20 ng/ml) for 5 min. Addition of U0126 or LY294002 clearly
suppressed activation of ERK or AKT, respectively (Fig. 2A).
Although the mobility shift was clearly visible in the presence of
LY294002, the addition of U0126 significantly diminished the
palladin gel shift (Fig. 2A). We also used HeLa cells that mainly
expressed 140 kDa form of palladin. Mobility shift of 140 kDa
form of palladin was inhibited by U0126 treatment as well
(Fig. 2B). To further confirm that MEK/ERK was responsible for
the phosphorylation, we expressed HA-palladin together with or
without active MEK. As shown in Figure 2C, HA-palladin only
showed a mobility shift in the presence of active MEK
(MEK1EEDN3) [33]. These results clearly indicate that MEK/
ERK regulates palladin phosphorylation. We examined palladin
localization and phosphorylated ERK after EGF stimulation.
MDA-MB-231 cells cultured on glass coverslips were stimulated
with EGF for 5 min, fixed by paraformaldehyde and then
immunostained for palladin and phosphorylated ERK. As shown
in Figure 2D, palladin and phosphorylated ERK colocalized to the
membrane edge after EGF stimulation.
N-terminal palladin serine residues are phosphorylated
To determine which residues were phosphorylated by the EGF
treatment, we deleted the N-terminus of palladin and examined its
gel shift. This palladin sequence has two proline-rich regions
between amino acids 65–100 and 180–220. The D102 and D219
deletions are missing the first or both proline rich regions,
respectively (Fig. 3A). We transiently expressed Myc-tagged full-
length, D102 or D219 palladin in Vero cells and examined
mobility shifts by EGF stimulation. Although a slower migrating
form of D102 appeared due to EGF stimulation, D219 did not
show any mobility shift (Fig. 3B). To narrow down the
phosphorylated region, we created D197 and D190, i.e., amino
acids 1–197 and 1–190 were deleted, respectively. As shown in
Figure 3C, a mobility shift was only observed for D190 and not for
D197. There is only one serine residue (Ser197) in this region.
Therefore, we mutated this residue to glycine (S197G) in D190
and examined the gel shift. EGF treatment did not induce a D190-
S197G mobility shift, which suggested that Ser197 is phosphor-
ylated in response to EGF (Fig. 3D).
Figure 3. Ser197 is phosphorylated by EGF stimulation. (A) Schematic representation of palladin deletion constructs. (B) Mobility shift of
mutant palladin after EGF stimulation was examined by western blot. Vero cells were transfected with Myc-tagged mutant palladin. Twenty-four
hours later, serum-starved cells were stimulated with or without EGF for 5 min and lysed for western blot analysis. Lower panel shows ERK
phosphorylation. (C) Mobility shift of mutant palladin after EGF stimulation was examined by western blotting. (D) Mobility shifts of D190-wt and
D190-S190G after EGF stimulation were examined by western blotting. Amino acid sequence from 190–197 is indicated.
doi:10.1371/journal.pone.0029338.g003
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phosphorylated after EGF stimulation, we substituted Ser197 in
full-length and D102 palladin to glycine (FL-S197G and D102-
S197G). FL-S197G, but not D102-S197G, showed a mobility shift
due to EGF stimulation (Fig. 4A), which suggested there are other
phosphorylated residues in the N-terminal region. Deletion of 44
amino acids in the N-terminus did not eliminate the palladin gel
shift in the S197G mutant (D44-S197G) (Fig. 4B). We used
ScanSite [34] to search for candidate residues for phosphorylation
between residues 45–102 and found that Ser77 was most likely to
be phosphorylated by ERK. Substitution of both Ser77 and
Ser197 in D44-palladin (D44-S77.197G) clearly reduced the
mobility shift compared to D44-S197G (Fig. 4C). We also used
full-length palladin with substitutions of both serine residues (FL-
S77.197G). As shown in Figure 4D, the mobility shift of FL-
S77.197G was reduced compared to both FL-S77G and FL-
S197G. In addition, western blot analysis with an anti-MPM-2
antibody revealed a significant reduction of FL-S77.197G
phosphorylation after EGF stimulation (Fig. 4E).
To confirm that ERK directly phosphorylates palladin, we
performed in vitro kinase assays. We used GST-fused N-terminal
palladin (amino acids 45–249) purified from bacteria as a
substrate. As shown in Figure 5, phosphorylation of Ser77- and
Ser197-substituted palladin was significantly reduced compared to
wild-type palladin. Taken together, these results clearly indicate
that Ser77 and Ser197 are phosphorylated by ERK.
Palladin phosphorylation by ERK regulates cell migration
ERK activation regulates various physiological functions,
including cell migration. To investigate whether palladin phos-
phorylation by ERK regulates cell migration, we established cell
lines that expressed wild-type or mutant palladin. We first
established MDA-MB-231 cells that constitutively expressed
GFP, GFP-wt (GFP-tagged full-length palladin) and GFP-
S77.197G (GFP-tagged full-length S77.197G palladin) using
retroviruses. We then infected a retrovirus that encoded an
shRNA for luciferase into GFP-expressing cells, and an shRNA for
palladin into GFP, GFP-palladin and GFP-S77.197G-expressing
cells. These four cell lines were designated shLuc/GFP, shPal/
GFP, shPal/GFP-wt and shPal/GFP-S77.197G, respectively.
Expression of endogenous palladin was significantly suppressed
in shPal/GFP, shPal/GFP-wt and shPal/GFP-S77.197G cells (Fig.
S1A). Both shPal/GFP-wt and shPal/GFP-S77.197G cells ex-
pressed levels of exogenous palladin comparatively higher than
Figure 4. Ser77 is phosphorylated by EGF stimulation. (A) Vero cells were transfected with the indicated mutant palladin. Twenty-four hours
later, serum-starved cells were stimulated with EGF for 5 min. Mobility shifts were examined by western blotting. (B) Mobility shifts of D44-S197G and
D102-S197G were examined by western blotting. (C) Amino acid sequence from 45 to 102 is indicated. Mobility shift of the indicated mutant palladin
was examined by western blotting. (D) Mobility shift of the indicated mutant palladin was examined by western blotting. (E) Vero cells were
transfected with either FL-wt or FL-S77.197G palladin. Twenty-four hours later, cells were stimulated with EGF for 5 min. Cells were lysed and
immunoprecipited with anti-Myc antibody and blotted with anti-MPM2 antibody.
doi:10.1371/journal.pone.0029338.g004
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silencing of palladin expression suppressed actin stress fiber
formation. Expression of either wild-type or mutant palladin
recovered stress fiber formation similar to shLuc/GFP cells
(Fig. 6A). Previous studies have shown that palladin overexpression
induced formation of thick actin filaments [11]. To address
whether ERK phosphorylation is required for this process, we
transiently overexpressed wild-type or mutant palladin in Cos7
cells and observed stress fiber formation. Expression of both wild
type and mutant palladin resulted in the production of thick actin
stress fibers (Fig. 6B), suggesting that ERK-mediated palladin
phosphorylation is not essential for the organization of stress fibers.
We tested if palladin phosphorylation was associated with
dynamic actin remodeling such as production of lamellipodia. We
stimulated shPal/GFP-wt and shPal/GFP-S77.197G cells with
EGF and fixed 5 min later to immunostain for actin cytoskeleton.
Production of lamellipodia and disruption of stress fiber upon EGF
stimulation was observed in these cells. (Fig. S2). Quantification of
these results suggested that palladin phosphorylation was not
required for the EGF-mediated formation of lamellipodia in
MDA-MB-231 cells (Fig. S2).
We next examined cell migration using a modified Boyden
chamber. As shown in Figure 6C, suppression of palladin
expression enhanced cell migration, but the re-expression of
wild-type palladin (shPal/GFP-wt) reduced migration to levels
similar to shLuc/GFP cells. Interestingly, migration of shPal/
GFP-S77.197G cells was around 24% faster than shPal/GFP-wt
cells. To further confirm this result, we used MCF10A cells and
established the same series of cell lines (Fig. S1B). Consistent with
the MDA-MB-231 cells, MCF10A cells that expressed non-
phosphorylated palladin showed enhanced migration compared to
wild-type palladin expressing cells (Fig. 6D). These results suggest
that palladin phosphorylation by ERK has an anti-migratory
function in these cell lines.
Small GTPases are central players for the regulation of cell
migration. We examined whether activation of Rac and Cdc42 is
related to the phosphorylation status of palladin. ShPal/GFP-wt
and shPal/GFP-S77.197G cells were serum-starved and stimulat-
ed with EGF, and then active Rac and Cdc42 was affinity
precipitated by GST-fused PAK-PBD. We found that both Rac
and Cdc42 were similarly activated in these cells (Fig. 6E),
indicating that activation of Rac and Cdc42 in response to EGF is
independent of the phosphorylation of palladin by ERK. The
result suggests that ERK-mediated phosphorylation of palladin
utilizes different pathways other than Rac and Cdc42 to control
cell migration.
Palladin phosphorylation affects association with Abl
To determine the molecular mechanism by which palladin
phosphorylation regulates cell migration, we tested if phosphor-
ylation affects palladin interactions with other molecules. Associ-
ation of the proline rich region and the SH3 domain is essential for
the signal transduction in response to extracellular stimuli. Since
the phosphorylated serines are localized in the proline-rich
regions, we speculated that the phosphorylation may affect
association of palladin with SH3 domain. We created GST-fused
SH3 for Abl and ArgBP2 and performed pull-down assays. Both
proteins are known to regulate cell migration [35,36], and a
previous study has shown the association of palladin with the
ArgBP2 SH3 [14]. 293T/HA-wt cells were treated with or without
EGF, and cell lysates were mixed with GST-fused proteins bound
to glutathione beads. Interacting proteins were affinity precipitat-
ed. As shown in Figure 7A, the palladin interaction with the Abl
SH3, but not the ArgBP2 SH3, was significantly reduced by
phosphorylation. We also examined the association of palladin
with other known interacting proteins, e.g. profilin, alpha-actinin
and CLP36, but phosphorylation did not affect these interactions
(Fig. S3). If the phosphorylations of Ser77 and Ser197 were
responsible for the inhibition of this interaction, the Abl SH3
would bind to S77.197G-palladin derived from EGF-treated cells.
We first examined whether the substitution of Ser77 and Ser197
would affect the interaction. As shown in Figure 7B, the Abl GST-
SH3 affinity precipitated HA-Ser77.197G-palladin to a level
similar to wild-type palladin. We then examined the interaction of
the Abl SH3 and mutant palladin in EGF-treated or non-treated
cells. As shown in Figure 7C, HA-Ser77.197G-palladin in either
EGF-treated or non-treated cells similarly associated with the Abl
SH3.
We next tested if Abl was associated with palladin in cells.
Palladin was immunopreciptiated from lysates of MDA-MB-231
cells and the immunoprecipitates were probed with anti-Abl
antibody by immunoblotting. Abl was co-immunoprecipitated by
anti-palladin antibody, but not by control antibody, indicating the
interaction of both proteins in cells (Fig. 7D). We then examined
the interaction after EGF stimulation. As shown in figure 7E,
association of Abl with palladin was reduced by EGF stimulation.
These results suggest that phosphorylation of Ser77 and Ser197 by
ERK regulates the palladin interaction with the Abl SH3.
Finally, we examined whether Abl was essential for cell
migration. Both shPal/GFP-wt and shPal/GFP-S77.197G were
treated with an Abl kinase inhibitor, STI571, and the migration
was examined. We found that addition of STI571 suppressed
migration of both cells in a concentration dependent manner
(Fig. 7F). Furthermore, silencing of Abl by siRNA transfection
similarly suppressed cell migration (Fig. 7G). These results indicate
a possible involvement of palladin-Abl association for EGF-
mediated cell migration (Fig. 7H).
Discussion
Since its discovery in 2000, palladin has been known as a
phosphoprotein because its slower migrating form was often
Figure 5. ERK phosphorylates palladin in an in vitro kinase
assay. GST-fused residues 45–249 of wild-type or mutant palladin was
incubated with active ERK for 10 min at 37uC in the presence of
radioactive [c
322P]-ATP and separated by SDS-PAGE. Left panel shows
the phosphorylation of recombinant proteins, and the right panel
shows Coomassie blue staining of recombinant proteins.
doi:10.1371/journal.pone.0029338.g005
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PLoS ONE | www.plosone.org 7 December 2011 | Volume 6 | Issue 12 | e29338Figure 6. Phosphorylation of Ser77 and Ser197 controls cell migration. (A) Cells were cultured on glass coverslips for 24 h and fixed with
paraformaldehyde.Cellswerestainedwithrhodamine-conjugatedphalloidintovisualizetheactincytoskeleton.(Scalebar=15 mm)Toquantitatecellswith
stress fiber formation, 50 cells for each cell line were evaluated and the graph shows thepercentage of cells with stress fiber formation. Three independent
experiments were performed. Each bar represents mean 6 SD. (N.S; P.0.05, *P,0.01) (B) Cos7 cells were transfected with either GFP-wt or GFP-S77.197G
palladin. Twenty-four hours later, cells were fixed and stained with rhodamine-conjugated phalloidin. (Scale bar=15 mm) To quantitate cells with thick
stressfiber formation, 30transfected cells were evaluated and the graphshowsthe percentage ofcells withthickstress fiber formation.Three independent
experiments were performed. Each bar represents mean 6 SD. (N.S; P.0.05) (C) Cell migration was examined using a modified Boyden chamber. Three
independent experiments were performed, and relative ratios of migrated cells are indicated (means6SD; *P,0.01). (D) Cell migration was examined using
a modified Boyden chamber. Three independent experiments were performed, and relative ratios of migrated cells are indicated (means 6SD; *P,0.01).(E)
shPal/GFP-wt and shPal/GFP-S77.197Gcells (MDA-MB-231)were serum-starved and stimulated withEGF for theindicated time points. Cells were lysed and
incubated with GST-fused GST-PAK-PBD fusion protein bound to glutathione-agarose beads. Beads were subjected to western blot with anti-Rac or anti-
Cdc42 antibody. Total Rac or cdc42 protein was detected by immunoblotting of cell lysates.
doi:10.1371/journal.pone.0029338.g006
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PLoS ONE | www.plosone.org 9 December 2011 | Volume 6 | Issue 12 | e29338observed by western blotting. However, the identities of the
protein kinases that phosphorylate palladin have remained elusive.
A recent study has shown that AKT1 phosphorylates palladin to
modulate its activity in bundling actin stress fibers and to inhibit
cell migration [19]. In this report, we showed evidence that
palladin is also phosphorylated by ERK in response to growth
factor stimulation. Addition of MEK inhibitor clearly suppressed
palladin phosphorylation upon EGF treatment. In addition,
expression of active MEK alone was sufficient to phosphorylate
palladin. Furthermore, in vitro kinase assays demonstrated direct
palladin phosphorylation by active ERK. These results clearly
show that palladin is a novel substrate of ERK. By making deletion
constructs and point mutations, we identified Ser77 and Ser197 as
residues phosphorylated by ERK. Both serine residues are
conserved in the previously identified mouse palladin [5]. Mobility
shifts due to EGF treatment were clearly suppressed by the
substitution of both serine residues. In vitro kinase assays also
demonstrated a significant reduction of palladin phosphorylation
after the substitution of both residues. Although we cannot rule out
the possibility that there are other residues that could be
phosphorylated by ERK because minor phosphorylation was
observed by an in vitro kinase assay, our results clearly show that
Ser77 and Ser197 are phosphorylated by ERK.
Palladin is known as a critical factor in regulating actin
cytoskeletal organization and cell migration [2]. Consistent with
previous findings, palladin silencing disrupted stress fiber forma-
tion [5], which was restored by the re-expression of palladin.
There have been two distinct reports regarding the role of palladin
in cell migration. One report showed cell migration inhibition due
to palladin knockdown [7]. The other demonstrated an anti-
migratory palladin function [19]. We produced MCF10A and
MDA-MB-231 cells that constitutively reduced palladin expression
using shRNA and observed enhanced cell migration. Moreover,
palladin re-expression reduced cell migration to levels similar to
control cells, which confirmed the inhibitory palladin function in
migration. Disruption of actin cytoskeleton can sometimes
accelerate cell migration. For example, addition of Rho kinase
inhibitor, which inhibits actin cytoskeletal organization, promotes
migration of certain cell lines [37,38]. Therefore, disruption of
actin cytoskeleton may have promoted migration of palladin-
knockdown cells. Although further studies are required to
determine the exact function of palladin in cell migration, our
results show a clear anti-migratory role for palladin in these cell
lines.
A number of studies have demonstrated that ERK activation is
essential for migration of numerous cell types [20]. We speculated
that palladin phosphorylation is required for ERK-mediated
promotion of cell migration. Contrary to our speculation,
S77.197G-palladin expression in MDA-MB-231 and MCF10A
cells enhanced migration compared to wild-type palladin.
Suppression of ERK activation by a chemical inhibitor reduced
cell migration of both the MDA-MB-231 and MCF10A cell lines
(data not shown). Therefore, ERK activation is essential for the
migration of these cell lines. ERK phosphorylates a variety of
proteins that are involved in actin cytoskeletal remodeling to
enhance migration. Most of these phosphorylations promote cell
migration, but our results indicate that some ERK phosphoryla-
tions may have anti-migratory roles. ERK stimulates both
activating and inhibitory signals for migration simultaneously,
and ERK-mediated promotion of cell migration may be
accomplished by the dominant effects of promoting signals.
To examine the molecular mechanism of palladin phosphory-
lation by ERK in regards to how it inhibits cell migration, we
checked activation of small GTPases, Rac1 and Cdc42, which are
critically involved in cell migration. We did not observe any
difference in activation of both GTPases between shPal/GFP-wt
and shPal/GFP-S77.197G cells. Previous studies have shown that
palladin phosphorylation by AKT1 can suppress cell migration
and induce bundling of actin filaments [19]. However, our results
showed that palladin phosphorylation by ERK was not required
for maintenance of the organized actin cytoskeleton and actin
bundling. These results suggest that ERK-mediated palladin
phosphorylation utilizes different molecular mechanisms to control
cell migration. We speculated that phosphorylation may affect
palladin associations with other molecules because phosphorylated
residues are localized in proline-rich regions. We found that the
association of palladin and the Abl SH3 domain was significantly
reduced by phosphorylation. The association of palladin with the
ArgBP2 SH3 was not affected by phosphorylation, which
indicated that phosphorylation regulates interactions with specific
proteins. Abl is known to promote lamellipodia formation and cell
migration [35]. Therefore, Abl dissociation from palladin may
inhibit Abl-mediated cell migration. However, since palladin has
multiple interacting proteins, there may be other interactions
regulated by phosphorylation to control cell migration.
Interactions of proline-rich regions and SH3 domains are
essential for various signal transductions that regulate prolifera-
tion, differentiation, migration and transformation [39]. Although
a large number of SH3-mediated interactions have been reported,
little is known about the regulatory mechanisms of these
interactions. SH3 and proline-rich regions form stable complexes,
but our results imply that this interaction can be regulated by
Figure 7. Phosphorylation of Ser77 and Ser197 regulates palladin association with Abl. (A) Serum-starved 293T/HA-wt cells were either
stimulated or non-stimulated with EGF for 5 min, and cell lysates were affinity precipitated with the indicated recombinant proteins (SH3-Abl; aa66–
118, SH-ArgBP2; aa432–666). Lower panels show the Coomassie blue staining of recombinant proteins. (B) HEK 293T cells were transfected with either
HA-tagged palladin (HA-wt) or HA-tagged S77.197G palladin (HA-S77.197G). Twenty-four hours later, cells were lysed and affinity precipitated with
GST-SH3-Abl protein bound to glutathione agarose. Immunoprecipitates were blotted with anti-HA antibody. Lower panel shows the Coomassie blue
staining of the GST-SH3 Abl protein. (C) Serum-starved 293T/HA-S77.197G cells were either stimulated or non-stimulated with EGF for 5 min, and cell
lysates were affinity precipitated with GST-SH3-Abl protein bound to glutathione agarose. Immunoprecipitates were blotted with anti-HA antibody.
(D) MDA-MB-231 cells were lysed and immunprecipitated with either control IgG or anti-palladin antibody. The lysates were blotted with anti-Abl or
anti-palladin antibody. The arrow indicates Abl and the arrowheads indicate palladin. The band around 140 kDa is an alternative form of palladin. (E)
MDA-MB-231 cells were serum-starved and stimulated with or without EGF and lysed for immunopreciptation. The lyates were blotted with anti-Abl
and anti-palladin antibodies. The graph shows the relative band intensity of immunoprecipitated Abl from three independent experiments. (F)
Migration of shPal/GFP-wt and shPal/GFP-S77.197G cells (MDA-MB-231) was examined in the presence of indicated concentrations of STI571. Relative
ratio of migrated cells was normalized by the number of migrating cells in the absence of STI571. Three independent experiments were performed
and the data are shown as mean 6SD. (G) shPal/GFP-wt and shPal/GFP-S77.197G cells (MDA-MB-231) were transfected with either luciferase (Luc) or
Abl siRNA and 48 h later, cell migration was examined. Relative ratio of migrated cells was normalized by the number of migrating shPal/GFP-wt cells
transfected with Luc siRNA. Three independent experiments were performed and the data are shown mean 6SD (*P,0.01). Expression of Abl after
siRNA transfection was examined by immunoblot. (H) Schematic presentation of regulation of cell migration by palladin phosphorylation.
doi:10.1371/journal.pone.0029338.g007
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reveal that SH3-mediated interactions are not stable, but
reversibly regulated by phosphorylation by various protein kinases.
In summary, we have shown that palladin is a novel substrate of
ERK and identified serine residues that are phosphorylated by
ERK. Furthermore, we have shown that phosphorylation has anti-
migratory functions and can inhibit the association of palladin
with Abl. In addition to ERK and AKT1, there may be other
kinases that phosphorylate palladin to regulate the actin
cytoskeletal organization. Further studies are required to elucidate
the molecular mechanism by which palladin regulates the integrity
of the actin cytoskeleton and cell migration.
Supporting Information
Figure S1 Expression of endogenous and exogenous
palladin in each cell line. (A) Expression of endogenous
palladin and exogenously expressed proteins in the indicated cell
lines were examined by western blotting. An arrow indicates
exogenously expressed palladin, and an arrowhead indicates
endogenous palladin. (B) Endogenous palladin expression and
exogenously expressed proteins in the indicated cell lines were
examined by western blotting.
(TIF)
Figure S2 shPal/GFP-wt and shPal/GFP-S77.197G cells
were serum-starved and stimulated with EGF for 5 min.
Cells were fixed and immunostained with rhodamin-conjugated
phalloidin. (Scale bar=10 mm) The arrows indicate lamellipodia
formation. The graph shows the ratio of cells with lamellipodia
formation. Thirty cells were evaluated for lamellipodia formation
and three independent experiments were performed. The data are
shown as mean 6SD. (N.S; P.0.05).
(TIF)
Figure S3 The phosphorylation of palladin does not
affect the interaction with profilin, alpha-actinin, and
CLP36. 293T/HA-wt cells were either stimulated or non-
stimulated with EGF for 5 min, and cell lysates were affinity
precipitated with the indicated recombinant proteins. The
precipitate were immnoblotted with anti-HA antibody. Lower
panels show the Coomassie blue staining of recombinant proteins.
(TIF)
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